I. INTRODUCTION
Rapid detection of pathogenic organisms in complex media is critical to ensure water quality, food safety, management of infectious disease, reliable agricultural production, and as a counter measure against biological weapons. While many sophisticated biosensors and assay methods have been developed for detecting pathogenic microorganisms, much of the effort has focused only on detection as a stand-alone task while the importance of, and challenges in, sample preparation prior to detection have been largely overlooked. Most detection methods use a very small sample volume, which limits the power to detect small quantities of pathogens dispersed in large quantities of material such as food or water. 1 Thus, being able to concentrate bacteria in small volumes of sample designed for analysis is of paramount importance to the development of advanced biosensing methods. For instance, a submicron superparamagnetic anion exchanger (SiMAG-DEAE, Chemicell, Berlin, Germany) was used to target dilute aqueous solutions as a method to improve sensitivity for subsequent polymerase chain reaction detection. 2 Collection and concentration of bacteria have also been achieved via ion-exchange, immunoaffinity, lectins, and metal hydroxides, as well as centrifugation, filtration, aqueous two-phase partitioning, and magnetic separation. [3] [4] [5] Gallium arsenide (GaAs) is a popular photonic material found in fabrication of semiconductor lasers and light emitting devices. We have recently demonstrated rapid detection of Escherichia coli at 10 3 CFU/ml, 6, 7 and Legionella pneumophila at 10 4 CFU/ml, 8 using photoluminescence (PL) emitting GaAs/AlGaAs microstructures. The detection sensitivity of such photonic biosensors depends on the efficiency of bacteria immobilization on their surfaces. This also applies to other biosensing platforms, such as that represented by a quartz crystal microbalance biosensor designed for specific capture of bacteria on gold surfaces. 9 Thus, concentrating the bacteria near, or at the surface of such biosensors could potentially result in increased sensitivity of these devices. We postulated that chemotaxis could be used as an efficient and simple way to enhance detection of bacteria. Chemotaxis (or more accurately, chemokinesis) is the process by which a cell alters its speed or frequency of turning in response to an extracellular chemical signal and permits drift toward spatial regions optimum for growth and survival (e.g., with high nutrient concentration). 10 This has been shown for E. coli or Salmonella to involve a motile system consisting of several helical flagella, each with a rotary a) Author to whom correspondence should be addressed; electronic mail: jan.j.dubowski@usherbrooke.ca. URL: www.dubowski.ca motor at their base, embedded in the cell wall. 10 If the motor turns counter-clockwise, the flagella come together to form a spinning bundle and the cell swims forward (a run) for 1.0 s. If one or more of the motors turn clockwise, the bundle becomes unstable, and the cell turns at random (a tumble) for 0.1 s, with no net displacement. The purpose of a tumble is to reorient the cell to a new (random) direction. In the absence of an attractant gradient, this results in a diffusive random walk with a diffusion constant of 4 Â 10 À6 cm 2 /s. [10] [11] [12] The E. coli chemotaxis pathway is so sensitive that it is able to sense a change in a few molecules of attractants. 13 In the presence of a gradient of attractant (or repellent), the bacteria use temporal comparisons of the attractant concentration over the preceding %3-4 s to determine if conditions are improving or deteriorating. 14, 15 If the tumbles are suppressed, cells move in a favorable direction. Conversely, when conditions deteriorate, the cell increases its chances of finding a favorable new direction by tumbling. This combination of run-and-tumble swimming and bias control leads to a drift velocity (in steep gradient of attractant) of around %7 lm/s.
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In this manuscript, we investigate the use of chemotaxis to enhance E. coli K12 and L. pneumophila immobilization on immune-recognition layer biofunctionalized GaAs (001) biochips by attaching b-galactosidase to the biochip surface to create a glucose/galactose gradient by lactose hydrolysis 17 inducing chemotaxis of flagellated bacteria toward the surface where they could be captured by specific antibodies also bound to the biochip surface. 18 
II. EXPERIMENT A. Materials
Polyclonal antibodies against L. pneumophila coupled with biotin and unconjugated anti-E. coli antibodies were obtained from ViroStat, Inc. (Portland, Marine). E. coli K12 were provided from the bacterial collection of the Biology Department of the Universit e de Sherbrooke Faculty of Sciences. E. coli carry peritrichous flagella. 19 L. pneumophila ssp1 were provided by Magnus (Boucherville, Canada). These bacteria carry a single monopolar flagellum. 20 BCYE agar medium was provided by Becton, Dickinson and Company (Sparks, MD, USA). Neutravidin was obtained from Molecular Probes Invitrogen (Burlington, Canada). HS-CH 11 -EG 3 -biotin (Biotinylated polyethylene glycol (PEG) thiol) was obtained from ProChimia Surfaces (Gdansk, Poland). 16-mercaptohexadecanoic acid (MHDA), 11-mercaptoundecanoic acid (MUDA), N-(3-dimethylaminopropyl)-N 0 -ethylcarbodiimide (EDC), N-hydroxysuccinimide (NHS), b-galactosidase, Luria Bertani broth, lactose, and phosphate buffered saline (PBS) solution were purchased from Sigma-Aldrich, Oakville, Canada. OptiClear, acetone, anhydrous ethanol, and isopropanol (2-propanol) were obtained from National Diagnostics (Mississauga, Canada), ACP (Montreal, Canada), Commercial Alcohols, Inc. (Brampton, Canada), and Fisher Scientific (Ottawa, Canada), respectively. Ammonium hydroxide (28%) was obtained from Anachemia (Richmond, Canada). Water was deionized to 18.2 MX resistance (DI water) with a Millipore purification custom system built by Culligan (Quebec, Canada). Wafers of GaAs (001), series VW 10680-53 and 54, were bought from Wafer Technology, Ltd. (Milton Keynes, UK).
B. Biochip functionalization

GaAs surface cleaning
Chips of 2 Â 2 mm, obtained by cleaving GaAs (001) wafers, were cleaned sequentially for 5 min in an ultrasonic bath of undiluted OptiClear, acetone, and isopropanol. The chips were then dried using a flow of high-purity (99.9995%) compressed nitrogen and etched with a solution of concentrated ammonium hydroxide (28%) for 2 min at room temperature to remove surface native oxides, such as Ga 2 O 3 , As 2 O 5 , and As 2 O 3 .
Binding architectures
Two recognition layer architectures were investigated: MUDA thiol and PEG-biotin thiol, for the immobilization of E. coli and L. pneumophila, respectively. a. MUDA thiol based architecture. Reference MUDA GaAs biochips: The cleaned GaAs chips were immersed for 20 h in MUDA thiol solution (0.5 mM) in degassed anhydrous ethanol. Consequently, the thiol modified surface was activated using a mixture of EDC (0.1 mM) and NHS (0.4 mM) prepared in 18.2 MX resistance DI water. The activated chips were incubated in a solution of unconjugated E. coli antibody in PBS (100 lg/ml) for 1 h. Finally, the antibody functionalized chips were incubated for 1 h in bovine serum albumin (BSA) (2%) in PBS to saturate the remaining active sites. We note that other thiol-based architectures have also been investigated for biofunctionalization of GaAs, [21] [22] [23] [24] and noble metal substrates. [25] [26] [27] MUDA GaAs biochips for chemotaxis: In order to induce chemotaxis, a supplementary functionalization step was integrated into the procedure: following the unconjugated E. coli antibody attachment step, the biochips were incubated for 1 h in 50 IU (1 IU corresponds to the quantity of enzyme that cleaves 1 lmol of lactose substrate into glucose and galactose per min at 25 C) of b-galactosidase in PBS solution. Figure 1 of antibody solution prepared in PBS (100 lg/ml) in a 0.5 ml tube. This step was carried out for 1 h at room temperature. We employed MHDA thiols rather than hexadecanethiol used previously, 6 to allow b-galactosidase immobilization as described in the below paragragh.
PEG-biotin/MHDA GaAs biochips for chemotaxis: The initial functionalization procedure was similar to that of the PEG-biotin functionalization of a reference biochip, but the procedure was modified to immobilize the b-galactosidase enzyme. Prior to neutravidin addition, the thiolated surface was activated for 30 min with EDC-NHS (0.4/0.1 M) prepared in DI water. The biochips were then incubated for 1 h in 50 UI b-galactosidase in PBS solution. The remaining active sites were blocked with a solution of 2% BSA. Neutravidin was added, and subsequent steps were followed as for the reference PEG-biotin biochips. Figure 1 (b) presents a schematic representation of the PEGbiotin based recognition layer architecture.
C. Reaction of functionalized surfaces with bacteria E. coli was grown overnight in Luria-Bertani broth. Colonies of L. pneumophila ssp1 on BCYE agar medium were suspended in PBS. After a centrifugation step (25 min at 3000 rpm) to remove culture medium and suspension in PBS, the concentration of the bacteria was quantified with a spectrophotometer (Thermo-Fisher, Model 40). By diluting, plating on petri dishes and counting the bacterial colonies, we determined that an optical density at 600 nm of 0.1 corresponded to 10 8 E. coli CFU/ml or 8 Â 10 7 L. pneumophila CFU/ml. Dilutions were carried out in PBS or in PBS plus lactose to reach final concentrations of bacteria at 10, 10 2 , 10 3 , and 10 4 CFU/ml. Bacteria would not be expected to multiply in PBS with only lactose as they require at least a source of nitrogen.
The E. coli K12 biofunctionalized chips were exposed to bacterial solutions at concentrations ranging from 0.5 Â 10 2 to 10 4 CFU/ml and incubated for 1 h in 0.5 ml microcentrifuge tubes. Exposure of L. pneumophila to biofunctionalized chips was carried out for 1 h in a 150 ll microfluidic chamber with concentrations ranging from 10 to 10 4 CFU/ml. No agitation or fluid flow was applied when attempting to bind either E. coli or L. pneumophila. After PBS washing, E. coli was quantified using an optical microscope (Zeiss, Axiotech) operating in a differential interference contrast mode, whereas L. pneumophila was quantified by incubating the biochips for 1 h in 50 lg/ml of fluorescein tagged anti-Legionella antibodies. These biochips were subsequently exposed to isopropanol for 1 h to inactivate L. pneumophila. The number of bound L. pneumophila was quantified by fluorescence microscopy using a fluorescence microscope (Olympus IX71). Numbers of bacteria were counted manually.
The PEG-biotin based architecture showed a high nonspecific interaction with E. coli K12, even at 2.5 Â 10 5 CFU/ml, leading to coverage of 55 6 8 bacteria per mm 2 in the absence of antibody. In the case of the MUDA based architecture (without antibody), only 1 6 0.5 bacteria per mm 2 were immobilized at a bacterial concentration of 2.5 Â 10 5 CFU/ml. On the other hand, L. pneumophila did not show a high affinity to neutravidin with a coverage not exceeding 0.25 bacteria/mm 2 for a bacterial concentration of 10 5 CFU/ml. Consequently, MUDA based architectures were used for E. coli K12 and PEG-biotin for L. pneumophila.
III. RESULTS AND DISCUSSION
A. Immobilization of E. coli K12
The E. coli functionalized reference and chemotaxis GaAs biochips were exposed separately to E. coli. As can be seen in Fig. 2 , for the reference biochip, 1 6 0.25, 4 6 1, and 13 6 2.5 bacteria were immobilized per mm . It can be seen that 4 6 1 of E. coli per mm 2 were immobilized under unassisted conditions from 10 3 CFU/ml. We note that detection of E. coli at 10 3 CFU/ml is the limit achieved with photocorroding GaAs/AlGaAs biochip microstructures functionalized with PEG-biotin/HDT (hexadecanethiol)-based architectures, 7 which could be associated with the presence of bacteria immobilized at such surface density. Thus, if assisted with chemotaxis, this same number of bacteria could be counted from a concentration of $60 CFU/ml, indicating a potential 16-fold sensitivity improvement of a photocorrosion based biosensor.
The enhancement of the number of E. coli K12 captured on the biochip that was induced by chemotaxis is presented as a function of the concentration of bacteria in Fig. 3 . It can be seen that the enhancement associated with chemotaxis is stronger at lower bacterial concentrations. Chemotaxis increased bacterial capture $1.8 times at 10 4 CFU/ml, but 11 times more bacteria were captured from a bacterial solution at 10 2 CFU/ml.
B. Immobilization of L. pneumophila L. pneumophila functionalized reference and chemotaxis GaAs biochips were exposed separately to 10, 10 2 , 10 3 , and 10 4 L. pneumophila CFU/ml. Without chemotaxis, $0.75, 12 6 1.5, 19 6 1.5, and 23 6 2 bacteria, respectively, were immobilized per mm 2 whereas with chemotaxis, immobilization of 6 6 0.25, 28 6 1, 41 6 3, and 42 6 2 bacteria per mm 2 , respectively, were observed. These results are summarized in Fig. 4 . We have reported that the lower limit of detection by PL for L. pneumophila was 10 4 CFU/ml. 8 It can be seen that $23 L. pneumophila per mm 2 were immobilized under unassisted conditions at the concentration of 10 4 CFU/ ml. In contrast, this same number of bacteria could be immobilized by a chemotaxis-assisted process from a suspension at $70 CFU/ml, which is 140 times less.
The enhancement of the surface capture of L. pneumophila that was induced by chemotaxis is presented as a function of the concentration of bacteria in Fig. 5 . It illustrates that chemotaxis again plays a more important role at lower concentrations of bacteria, with more than eight times enhanced bacterial immobilization observed for 10 CFU/ml. The enhancement factor falls below 2 for 10 4 CFU/ml. We have reported that with similar MUDA-antibody or PEG-biotin-neutravidin-biotinylated antibody architectures we were able to detect E. coli at 10 3 CFU/ml, 7 and L. pneumophila at 10 4 CFU/ml. 8 In fact, to ensure PL detection, a critical minimum number of bacteria should be immobilized on the surface. Other detection methodologies also require critical minimum numbers of bacteria immobilized on the surface to yield a positive signal. For E. coli and L. pneumophila, immobilization of bacteria at concentrations under the detection limits can be visualized microscopically, [6] [7] [8] but the achieved coverage was not enough to induce PL signal variation of photocorroding GaAs/AlGaAs biochips. We have thus employed microscopic visualization and counting of bacteria to quantify the effect of chemotaxis. We propose that chemotaxis could improve the sensitivity of PL detection of E. coli and L. pneumophila by 16 to 140-fold. The sensitivity of detection of other detection strategies could also, no doubt, be improved by chemotaxis.
We propose that the mechanism of action of chemotaxis depends on the generation of glucose at the surface of the biochip. Glucose is the preferred energy and carbon source for most, if not all, microorganisms. In the presence of glucose and lactose, lactose use is repressed until all of the glucose is consumed giving rise to diauxic growth. 28 Chemotaxis, thus, attracts bacteria toward sources of glucose. In the absence of an attractant gradient, bacteria move in a diffusive random walk, whereas the presence of an attractant leads to a direction and increase in velocity. This directed motility of the bacteria together with an increased speed of movement explains why, in the case of chemotaxis, increased numbers of bacteria are immobilized on the biochip surface. Normally, negatively charged bacteria are repulsed from the negatively charged biochip surfaces. We propose that chemotaxis partially overcomes these repulsive forces by attracting bacteria toward the surface where they are captured by antibodies. Increasing concentrations of bacteria would increase the probability of random interactions with the surface and so chemotaxis would have less influence. Chemotaxis lured bacteria with food toward the surface where they were captured, analogous to the Sirens of Greek mythology, whose song lured sailors toward their islands where their ships were wrecked and thus immobilized on the rocks.
IV. CONCLUSIONS
We have investigated the influence of chemotaxis on the immobilization of E. coli K12 and L. pneumophila on antibody biofunctionalized GaAs (001) biochips. Chemotaxis was induced with the enzyme beta-galactosidase (b-gal) that together with its substrate lactose produced a gradient of glucose acting as a bacterial attractant toward the biochip surface. A comparison between bacteria immobilized on the reference (no b-gal) and chemotaxis assisted biochips revealed 11 and 8 times enhancement of the surface immobilized E. coli and L. pneumophila, respectively, for 10 2 and 10 CFU/ml concentrations of these bacteria. The enhancement factor decreased with increasing concentration of bacteria, and for 10 4 CFU/ml, it was reduced to less than 2. The results suggest that with chemotaxis, the GaAs/AlGaAs photonic biosensor has the potential to detect E. coli at 60 CFU/ ml or L. pneumophila at 70 CFU/ml. The sensitivity of detection of other detection strategies could also, no doubt, be improved by chemotaxis.
